Preclinical antitumour activity and animal toxicology studies of rhizoxin, a novel tubulin-interacting agentHENDRIKS, H. R; PLOWMAN, J; BERGER, D. P et al.Annals of oncology. 1992, Vol 3, Num 9, pp 755-763, issn 0923-7534Article

The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenograftsBREISTØL, K; HENDRIKS, H. R; BERGER, D. P et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1602-1606, issn 0959-8049Conference Paper

Preclinical phase II studies in human tumor xenografts : a European multicenter follow-up studyLANDON, S. P; HENDRIKS, H. R; BRAAKHUIS, B.-J. M et al.Annals of oncology. 1994, Vol 5, Num 5, pp 415-422, issn 0923-7534Article

Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenograftsHENDRIKS, H. R; LANGDON, S; BERGER, D. P et al.European journal of cancer (1990). 1992, Vol 28A, Num 4-5, pp 767-773, issn 0959-8049Article

Phase II preclinical drug screening in human tumor xenografts : a first european multicenter collaborative studyBOVEN, E; WINOGRAD, B; BERGER, D. P et al.Cancer research (Baltimore). 1992, Vol 52, Num 21, pp 5940-5947, issn 0008-5472Article

Combined in vitro/in vivo test procedure with human tumor xenografts for anticancer drug developmentFIEBIG, H. H; WINTERHALTER, B; BERGER, D. P et al.Strahlentherapie und Onkologie. 1989, Vol 165, Num 7, pp 522-524, issn 0179-7158, 3 p.Article

Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinomaNEUMANN, H. P. H; BENDER, B. U; LIPS, C. J. M et al.The Journal of urology. 1998, Vol 160, Num 4, pp 1248-1254, issn 0022-5347Article

EO9 : a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical modelsHENDRIKS, H. R; PIZAO, P. E; HORNSTRA, H. W et al.European journal of cancer. Part A. 1993, Vol 29, Num 6, pp 897-906Article

Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase α in human tumour lines : implications for in vitro chemoresistanceLICHT, T; BROSS, K. J; FIEBIG, H.-H et al.Journal of cancer research and clinical oncology. 1992, Vol 118, Num 2, pp 116-122, issn 0171-5216Article

Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacySCHWENDENER, R. A; FIEBIG, H. H; BERGER, M. R et al.Cancer chemotherapy and pharmacology. 1991, Vol 27, Num 6, pp 429-439, issn 0344-5704, 11 p.Article

Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitroLICHT, T; FIEBIG, H.-H; HERRMANN, F et al.International journal of cancer. 1991, Vol 49, Num 4, pp 630-637, issn 0020-7136Article

Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetinHOFMANN, J; FIEBIG, H. H; WINTERHALTER, B. R et al.International journal of cancer. 1990, Vol 45, Num 3, pp 536-539, issn 0020-7136Article

The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patientsBURGER, J. A; OCHS, A; WIRTH, K et al.Annals of oncology. 1997, Vol 8, Num 2, pp 200-202, issn 0923-7534Article

Monogenetic hypertension and pheochromocytomaNEUMANN, H. P. H; BENDER, B; ZÄUNER, I et al.American journal of kidney diseases. 1996, Vol 28, Num 3, pp 329-333, issn 0272-6386Article

Tuberous sclerosis complex with end-stage renal failureNEUMANN, H. P. H; BRÜGGEN, V; BERGER, D. P et al.Nephrology, dialysis, transplantation (Print). 1995, Vol 10, Num 3, pp 349-353, issn 0931-0509Article

Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologiesBERGER, D. P; HERBSTRITT, L; DENGLER, W. A et al.Annals of oncology. 1995, Vol 6, Num 8, pp 817-825, issn 0923-7534Article

In vitro and in vivo evaluation of US-NCI compounds in human tumor xenograftsFIEBIG, H.-H; BERGER, D. P; WINTERHALTER, B. R et al.Cancer treatment reviews. 1990, Vol 17, Num 2-3, pp 109-117, issn 0305-7372, 9 p.Article

Correlation of drug response in patients and in the clonogenic assay with solid human tumour xenograftsSCHOLZ, C. C; BERGER, D. P; WINTERHALTER, B. R et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 8, pp 901-905, issn 0277-5379Article

Preclinical phase II study of ifosfamide in human tumour xenographts in vivoBERGER, D. P; FIEBIG, H. H; WINTERHALTER, B. R et al.Cancer chemotherapy and pharmacology. 1990, Vol 26, pp S7-S11, issn 0344-5704, SupplConference Paper